Bilateral Scleritis as a Presenting Manifestation of Relapsing Polychondritis

Authors

  • Ana Pinho Serviço de Medicina Interna, Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos, Matosinhos, Portugal
  • Helena Greenfield Serviço de Medicina Interna, Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos, Matosinhos, Portugal
  • Francisca Beires Serviço de Medicina Interna, Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos, Matosinhos, Portugal
  • Ana P. Ferro Serviço de Medicina Interna
  • Mariana Taveira Unidade Cuidados Intermédios Polivalente, Departamento de Medicina, Hospital Pedro Hispano, Matosinhos, Unidade Local de Saúde de Matosinhos, Matosinhos, Portugal

DOI:

https://doi.org/10.60591/crspmi.50

Keywords:

Methotrexate, Polychondritis, Relapsing/diagnosis, Polychondritis, Relapsing/drug therapy, Scleritis/diagnosis

Abstract

Relapsing polychondritis is a rare inflammatory condition with poorly understood physiopathology and unclear origin. It is commonly characterized by recurrent episodes of inflammation involving cartilaginous tissues, predominantly those of the ears, nose and joints.  It may also have systemic manifestations, which can have potentially severe complications, such following respiratory tract involvement. Diagnosis is typically delayed, due to this vast clinical spectrum and there is no consensus on the ideal diagnostic approach or treatment choice.

We report the case of a patient presenting bilateral anterior nodular scleritis as the first manifestation of relapsing polychondritis. We attained disease control with methotrexate therapy, following recurrent disease upon tapering of high dose corticosteroids.

Downloads

Download data is not yet available.

References

Rednic S, Damian L, Talarico R, Scirè CA, Tobias A, Costedoat-Chalumeau N, et al. Relapsing polychondritis: state of the art on clinical practice guidelines. RMD Open. 2018;4:e000788. doi: 10.1136/rmdopen-2018-000788.

Lekpa FK, Chevalier X. Refractory relapsing polychondritis: challenges and solutions. Open Access Rheumatol. 2018;10:1-11. doi: 10.2147/OARRR.S142892.

Chen N, Zheng Y. Characteristics and clinical outcomes of 295 patients with relapsing polychondritis. J Rheumatol. 2021;48:1876-82. doi: 10.3899/jrheum.210062.

Fukuda K, Mizobuchi T, Nakajima I, Kishimoto T, Miura Y, Taniguchi Y. Ocular Involvement in Relapsing Polychondritis. J Clin Med. 2021 Oct 26;10(21):4970. doi: 10.3390/jcm10214970.

McAdam LP, O'Hanlan MA, Pearson RC. Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine. 1976;55:193–215.

Damiani JM, Levine HL. Relapsing polychondritis. Report of ten cases. Laryngoscope. 1979;89:929–46.

Michet CJ Jr, McKenna CH, Luthra HS, O'Fallon WM. Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann Intern Med. 1986;104:74-8. doi: 10.7326/0003-4819-104-1-74.

Rose T, Schneider U, Bertolo M, Klotsche J, Casteleyn V, Biesen R, et al. Observational study and brief analysis of diagnostic criteria in relapsing polychondritis. Rheumatol Int. 2018;38:2095-101. doi: 10.1007/s00296-018-4121-2.

Taniguchi Y, Nishikawa H, Nakayama S, Amano E, Terada Y. Clinical implications of ultrasonography in monitoring disease activity of relapsing polychondritis. Rheumatology. 2016;55:1250. doi: 10.1093/rheumatology/kew219.

Yoshida M, Taniguchi Y, Yoshida T, Nishikawa H, Terada Y. Ultrasonography of auricular cartilage is a potential tool for diagnosing relapsing polychondritis and monitoring disease activity . Int J Rheum Dis. 2021;10.1111/1756-185X.14256. doi:10.1111/1756-185X.14256

Dion J, Costedoat-Chalumeau N, Sène D, Cohen-Bittan J, Leroux G, Dion C, et al. Relapsing Polychondritis Can Be Characterized by Three Different Clinical Phenotypes: Analysis of a Recent Series of 142 Patients. Arthritis Rheumatol. 2016;68:2992-3001. doi: 10.1002/art.39790.

Moulis G, Sailler L, Pugnet G, Astudillo L, Arlet P. Biologics in relapsing polychondritis: a case series. Clin Exp Rheumatol. 2013;31:937-9.

Farhat R, Clavel G, Villeneuve D, Abdelmassih Y, Sahyoun M, Gabison E, et al. Sustained remission with tocilizumab in refractory relapsing polychondritis with ocular involvement: a case series. Ocul Immunol Inflamm. 2021;29:9-13. doi: 10.1080/09273948.2020.1763405.

Arnaud L, Devilliers H, Peng SL, Mathian A, Costedoat-Chalumeau N, Buckner J, et al. The Relapsing Polychondritis Disease Activity Index: development of a disease activity score for relapsing polychondritis. Autoimmun Rev. 2012;12:204-9. doi: 10.1016/j.autrev.2012.06.005.

Mertz P, Belot A, Cervera R, Chuah TY, Dagna L, Damian L, et al. The relapsing polychondritis damage index (RPDAM): Development of a disease-specific damage score for relapsing polychondritis. Joint Bone Spine. 2019;86:363-8. doi: 10.1016/j.jbspin.2018.11.001.

Published

05-06-2023

How to Cite

Pinho, A., Greenfield, H., Beires, F., P. Ferro, A., & Taveira, M. (2023). Bilateral Scleritis as a Presenting Manifestation of Relapsing Polychondritis. SPMI Case Reports, 1(2), 85–85. https://doi.org/10.60591/crspmi.50

Issue

Section

Casos Clínicos

Categories

Most read articles by the same author(s)